MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hon.2501

Медицинская библиотека · Hematological oncology · 2018

Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia Group.

Drozd-Sokołowska Joanna, Mądry Krzysztof, Waszczuk-Gajda Anna, Biecek Przemysław, Szwedyk Paweł, Budziszewska Katarzyna, Raźny Magdalena, Dutka Magdalena, Obara Agata, Wasilewska Ewa, Lewandowski Krzysztof, Piekarska Agnieszka, Bober Grażyna, Krzemień Helena, Stella-Hołowiecka Beata, Kapelko-Słowik Katarzyna, Sawicki Waldemar, Paszkowska-Kowalewska Małgorzata, Machowicz Rafał, Dwilewicz-Trojaczek Jadwiga

СтатьяПеревод в очереди

Аннотация

Atypical chronic myeloid leukaemia (aCML) belongs to myelodysplastic/myeloproliferative neoplasms. Because of its rarity and changing diagnostic criteria throughout subsequent classifications, data on aCML are very scarce. Therefore, we at the Polish Adult Leukemia Group performed a nationwide survey on aCML. Eleven biggest Polish centres participated in the study. Altogether, 45 patients were reported, among whom only 18 patients (40%) fulfilled diagnostic criteria. Among misdiagnosed patients, myelodysplastic/myeloproliferative syndrome unclassifiable and chronic myelomonocytic leukaemia were the most frequent diagnoses. Thirteen patients were male, median age 64.6 years (range 40.4-80.9). The median parameters at diagnosis were as follows: white blood cell count 97 × 109 /L (23.8-342) with immature progenitors amounting at 27.5% (12-72), haemoglobin 8.6 g/dL (3.9-14.9), and platelet count 66 × 109 /L (34-833). Cytoreductive treatment was used in all patients, and 2 patients underwent allogeneic hematopoietic stem cell transplantation. The median overall survival was 14.1 months (95% CI, 7.2), with median acute myeloid leukaemia-free survival of 13.3 months (95% CI, 3.6-22.6). Cumulative incidence of acute myeloid leukaemia transformation after 1 year in aCML group was 12.5% (95% CI, 0%-29.6%). To conclude, aCML harbours a poor prognosis. Treatment options are limited, with allogeneic hematopoietic stem cell transplantation being the only curative method at present, although only a minority of patients are transplant eligible. Educational measures are needed to improve the quality of diagnoses.

Для цитирования: Drozd-Sokołowska Joanna, Mądry Krzysztof, Waszczuk-Gajda Anna, Biecek Przemysław, Szwedyk Paweł, Budziszewska Katarzyna, Raźny Magdalena, Dutka Magdalena, Obara Agata, Wasilewska Ewa, Lewandowski Krzysztof, Piekarska Agnieszka, Bober Grażyna, Krzemień Helena, Stella-Hołowiecka Beata, Kapelko-Słowik Katarzyna, Sawicki Waldemar, Paszkowska-Kowalewska Małgorzata, Machowicz Rafał, Dwilewicz-Trojaczek Jadwiga. Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia Group.. Hematological oncology. 2018. DOI: 10.1002/hon.2501.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.